pharma · Hereditary Angioedema · Influenza · BCRX
Biocryst
Biocryst clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- München, DE
- Founded
- 1986
- Employees
- 6
- Programs
- 37
- Drugs
- 17
- Patents
- 72
Biocryst projects
10 ClinicalTrials.gov programs sponsored by Biocryst.
Biocryst has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BCX4161
Biocryst
Hereditary Angioedema
4 trials -
BCX7353
Biocryst
Hereditary Angioedema
4 trials -
BCX7353 capsules
Biocryst
Hereditary Angioedema
1 trial -
BCX7353 capsules
Biocryst
Hereditary Angioedema, HAE
1 trial -
Peramivir
Biocryst
Influenza
5 trials -
Peramivir
Biocryst
Seasonal Influenza
1 trial -
Peramivir 150mg
Biocryst
Influenza
1 trial -
Peramivir+SOC
Biocryst
Cough
1 trial -
avoralstat
Biocryst
Hereditary Angioedema
1 trial -
berotralstat
Biocryst
Hereditary Angioedema
2 trials
Frequently asked questions
How many clinical projects does Biocryst have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.